“NewYorkBIO thanks Dr. Marty Makary for his leadership as FDA Commissioner during a pivotal time for public health and biomedical innovation. We look forward to working with Acting Commissioner Kyle Diamantas, J.D., and continuing our engagement with FDA leadership during this transition. NewYorkBIO supports a strong, stable regulatory environment that bolsters innovation for companies in New York and across the United States.”

– Jennifer Hawks Bland, CEO, NewYorkBIO